Gurkamal Chatta

Nivolumab plus Gemcitabine–Cisplatin in Advanced Urothelial Carcinoma

Michiel S. van der Heijden, Guru Sonpavde, Thomas Powles et al. · New England Journal of Medicine · 2023 · 462 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Trastuzumab, Paclitaxel, Carboplatin, and Gemcitabine in Advanced Human Epidermal Growth Factor Receptor-2/ <i>neu</i> –Positive Urothelial Carcinoma: Results of a Multicenter Phase II National Cancer Institute Trial

Maha Hussain, Gary R. MacVicar, Daniel P. Petrylak et al. · Journal of Clinical Oncology · 2007 · 374 citations

Medicine, Oncology, Pharmacology +15

Double-Blinded Randomized Study of High-Dose Calcitriol Plus Docetaxel Compared With Placebo Plus Docetaxel in Androgen-Independent Prostate Cancer: A Report From the ASCENT Investigators

Tomasz M. Beer, Christopher W. Ryan, Peter Venner et al. · Journal of Clinical Oncology · 2007 · 310 citations · Full text

Medicine, Oncology, Urology +12

Loss of New Chemokine CXCL14 in Tumor Tissue Is Associated with Low Infiltration by Dendritic Cells (DC), while Restoration of Human CXCL14 Expression in Tumor Cells Causes Attraction of DC Both In Vitro and In Vivo

Galina V. Shurin, Robert L. Ferris, Irina L. Tourkova et al. · The Journal of Immunology · 2005 · 217 citations · Full text

Life Sciences, Immunology, Oncology +17

T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors

Takayoshi Yamauchi, Toshifumi Hoki, Takaaki Oba et al. · Nature Communications · 2021 · 187 citations · Full text

Medicine, Immunology, Oncology +17